Study on the porcinophilic foot-and-mouth disease virus I. Production and characterization of monoclonal antibodies against VP1

Journal of Veterinary Medical Science

Volumn 68, Issue 8, 2006, Pages 859-864

  Cheng, Ivan Chen ^a   Liang, Shu Mei ^b   Tu, Wen Jane ^c   Chen, Chi Min ^a   Lai, Siou Yu ^a   Cheng, Yung Chih ^b   Lee, Fan ^c   Huang, Tien Shine ^c   Jong, Ming Hwa ^c  

^a ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

ELISA; Foot and mouth disease virus; Monoclonal antibody; Neutralizing activity; VP1

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIBODY;

ANIMAL; ARTICLE; CELL LINE; CLASSIFICATION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; HAMSTER; IMMUNOLOGY; SWINE; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; SWINE;

FOOT-AND-MOUTH DISEASE VIRUS; SUS SCROFA;

EID: 33748459896     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.68.859     Document Type: Article

References (27)

1. Aggarwal, N. and Barnett, P.V. 2002. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. J. Gen. Virol. 83: 775-782.
2. Barnett, P.V., Samuel, A.R., Pullen,L., Ansell, D., Butcher, R.N. and Parkouse, R.M.E. 1998. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. J. Gen. Virol. 79: 1687-1697.
3. Beard, C.W. and. Mason, P.W. 2000. Genetic determinants of altered virulence of Taiwanese Foot-and-Mouth disease virus. J. Virol. 74: 987-991.
4. Crowther, J.R., Faris, S., Carpenter, Q.C. and Samuel, A.R. 1993. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J. Gen. Virol. 74: 1547-1553.
5. Dunn, C.S. and Donaldson, A.I. 1997. Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Vet. Rec. 141: 174-175.
6. Dunn, C.S., Samuel, A.R., Pullen, L.A. and Anderson, J. 1998. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Virology 247: 51-61.
7. Golding, S.M., Hedger, R.S. and Talbot, P. 1976. Radial immunodiffusion and serum neutralization techniques for the assay of antibodies to swine vesicular disease. Res. Vet. Sci. 20: 142-147.
8. Grubman, M.J. and Baxt, B. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17: 465-493.
9. Harlow, E. and Lane, D. 1988. Monoclonal antibodies. pp. 139-244. In: Antibodies a Laboratory Manual, Cold Spring Harbor Laboratory Press, New York.
10. Hong, T.H, Chen, S.T., Tang, T.K., Wang, S.C. and Chang, T.H. 1989. The production of polyclonal and monoclonal antibodies in mice using novel immunization methods. J. Immunol. Methods 120: 151-157.
11. Huang, C.C., Lin, Y.L., Huang, T.S., Tu, W.J., Lee, S.H., Jong, M.H. and Lin, S.Y. 2001. Molecular characterization of foot-and-mouth disease virus isolated from ruminants in Taiwan in 1999-2000. Vet. Microbiol. 81: 193-205.
12. Jackson, T., Sharma, A., Ghazaleh, R.A., et al. 1997. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro. J. Virol. 71: 8357-8361.
13. Kitson, J.D.A., McCahon, D. and Belsham, G.J. 1990. Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179: 26-34.
14. Mason, P.W., Reider, E. and Baxt, B. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. U.S.A. 91: 1932-1936.
15. Mason, P.W., Pacheco, J.M., Zhao, Q.Z. and Knowles, N.J. 2003. Comparisons of the complete genomes of Asian, African and European isolates of a recent foot-and-mouth disease virus type O pandemic strain (PanAsia). J. Gen. Virol. 84: 1583-1593.
16. Mateu, M.G., Da Silva, J.L., Rocha, E., De Brum, D.L., Alonso, A., Enjuanes, L., Domingo, E. and Barahona, H. 1988. Extensive antigenic heterogenicity of foot-and-mouth disease virus of serotype C. Virology 167: 113-124.
17. Mateu, M.G., Andreu, D. and Domingo, E. 1995. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210: 120-127.
18. Mateu, M.G. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structure reviews. Virus Res. 38: 1-24.
19. OIE (World Organization for Animal Health). 2004. Manual of Diagnosis Tests and Vaccines for Terrestrial Animals, 5th ed., Paris.
20. Pay, T.W.F. and Hingley, P.J. 1987. Correlation of 140S antigen dose with the serum neutralizing antibody response and level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 5: 60-64.
21. Reed, L.J. and Muench, H. 1938. A simple method of estimating fifty per cent end-points. Am. J. Hyg. 27: 493-497.
22. Sobrino, F., Saiz, M., Jimenez-Clavero, M.A., Nunez, J.I., Rosas, M.F., Baranowaki, E. and Ley, V. 2001. Foot-and-mouth disease virus: a long known virus, but a current threat. Vet. Res. 32: 1-30.
23. Tesar, M., Berger, H.-G. and Marquardt , O. 1989. Serological probes for some foot-and-mouth disease virus nonstructural proteins. Virus Genes 3: 29-44.
24. Tsai, C.P., Pan, C.H., Liu, M.Y., Lin, Y.L., Chen, C.M., Huang, T.S., Cheng, I.C., Jong, M.H. and Yang, P.C. 2000. Molecular epidemiological studies on foot-and-mouth disease type O Taiwan viruses from the 1997 epidemic. Vet. Microbiol. 74: 207-216.
25. Wang, J.-H., Liang, C.-M., Peng, J.-M., Shieh, J.-J., Jong, M.-H. Lin, Y.-L., Sieber, M. and Liang, S.-M. 2003. Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus. Vaccine 21: 3721-3729.
26. Xie, Q.-C., McCahon, D., Crowther, J.R., Belsham, G.H. and McCullough, K.C. 1987. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J. Gen. Virol. 68: 1637-1647.
27. Yang, P.C., Chu, R.M., Chung, W.B. and Sung, H.T. 1999. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet. Rec. 145: 731-734.